| Mr Konstantin V Turchaninov, MD, PHD | |
|
4315 Diplomacy Dr, Alaska Native Medical Center, Anchorage, AK 99508-5926 | |
| (907) 563-2662 | |
| Not Available |
| Full Name | Mr Konstantin V Turchaninov |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 9 Years |
| Location | 4315 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235420795 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 100639 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alaska Native Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Native Tribal Health Consortium | 6709780265 | 457 |
News Archive
Temporary staff members working in a hospital's fast-paced emergency department are twice as likely as permanent employees to be involved in medication errors that harm patients, new Johns Hopkins research suggests.
While measuring brain activity with magnetic resonance imaging during blood pressure trials, UCLA researchers found that men and women had opposite responses in the right front of the insular cortex, a part of the brain integral to the experience of emotions, blood pressure control and self-awareness.
Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.
Men with susceptibility for prostate cancer will soon be identifiable through a simple DNA test.
Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.
› Verified 4 days ago
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
Temporary staff members working in a hospital's fast-paced emergency department are twice as likely as permanent employees to be involved in medication errors that harm patients, new Johns Hopkins research suggests.
While measuring brain activity with magnetic resonance imaging during blood pressure trials, UCLA researchers found that men and women had opposite responses in the right front of the insular cortex, a part of the brain integral to the experience of emotions, blood pressure control and self-awareness.
Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.
Men with susceptibility for prostate cancer will soon be identifiable through a simple DNA test.
Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Konstantin V Turchaninov, MD, PHD 3625 Carleton Ave Apt B, Anchorage, AK 99517-1547 Ph: (907) 764-0051 | Mr Konstantin V Turchaninov, MD, PHD 4315 Diplomacy Dr, Alaska Native Medical Center, Anchorage, AK 99508-5926 Ph: (907) 563-2662 |
News Archive
Temporary staff members working in a hospital's fast-paced emergency department are twice as likely as permanent employees to be involved in medication errors that harm patients, new Johns Hopkins research suggests.
While measuring brain activity with magnetic resonance imaging during blood pressure trials, UCLA researchers found that men and women had opposite responses in the right front of the insular cortex, a part of the brain integral to the experience of emotions, blood pressure control and self-awareness.
Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.
Men with susceptibility for prostate cancer will soon be identifiable through a simple DNA test.
Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.
› Verified 4 days ago
Colby Parks, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: Providence Anchorage Anesthesia Medical Group, P.c., Suite 207, Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 | |
Thomas Weissmueller, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Providence Dr Ste 205, Anchorage, AK 99508 Phone: 907-561-1510 | |
Robert C Gudor, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2801 Debarr Rd, Anchorage, AK 99508 Phone: 907-258-2149 Fax: 907-258-2147 | |
Richard F Farah, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3300 Providence Dr, Suite 207, Providence Anchorage Anesthesia Medical Grou, Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 | |
Katharine Lamperti, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3300 Providence Dr., Suite 207, Providence Anchorage Anesthesia Medical Group, P.c., Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 | |
Harold W Schneider, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Mary R Lanza, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3300 Providence Dr Ste 207, Providence Anchorage Anesthesia Medical Group, P.c., Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 |